ADHD drug trial for teens halted early

NCT ID NCT06215144

First seen Jan 21, 2026 · Last updated May 16, 2026 · Updated 19 times

Summary

This study tested a new drug called NRCT-101SR to see if it could safely reduce ADHD symptoms in teenagers aged 13 to 17. The trial was stopped early, so results are limited. Participants were randomly assigned to receive the drug or a placebo, and researchers tracked symptom changes using standard ADHD rating scales.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Accel Research Sites - Lakeland Clinical Research Unit

    Lakeland, Florida, 33803, United States

  • Accel Research Sites Network - Maitland

    Maitland, Florida, 32751, United States

  • Advanced Research Center, Inc

    Anaheim, California, 92805, United States

  • Bio-Medical Research LLC

    Miami, Florida, 33144, United States

  • Boston Clinical Trials Llc

    Boston, Massachusetts, 02131, United States

  • CenExel ACMR Atlanta Center for Medical Research

    Atlanta, Georgia, 30331, United States

  • CenExel iRS - iResearch Savannah

    Savannah, Georgia, 31405, United States

  • Coastal Carolina Research Center - North Charleston

    North Charleston, South Carolina, 29405, United States

  • DelRicht Research

    New Orleans, Louisiana, 70155, United States

  • DelRicht Research

    Prairieville, Louisiana, 70769, United States

  • Epic Medical Research - DeSoto

    DeSoto, Texas, 75115, United States

  • Vector Clinical Trials

    Las Vegas, Nevada, 89128, United States

  • iResearch Atlanta

    Decatur, Georgia, 30030, United States

Conditions

Explore the condition pages connected to this study.